Cargando…
Clinical and reproductive outcomes of fertility-sparing surgery in stage I epithelial ovarian cancer
The aim of the present study was to evaluate the oncologic safety and reproductive outcome in patients with stage I epithelial ovarian cancer (EOC) treated with fertility-sparing surgery (FSS). Women aged ≤40 years with stage I EOC who had undergone FSS between 2000 and 2010 were retrospectively rev...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6904870/ https://www.ncbi.nlm.nih.gov/pubmed/31832189 http://dx.doi.org/10.3892/mco.2019.1954 |
_version_ | 1783478067697549312 |
---|---|
author | Watanabe, Takafumi Soeda, Shu Nishiyama, Hiroshi Kiko, Yuichiroh Tokunaga, Hideki Shigeta, Shogo Yaegashi, Nobuo Yamada, Hidekazu Ohta, Tsuyoshi Nagase, Satoru Shoji, Tadahiro Kagabu, Masahiro Baba, Tsukasa Shimizu, Dai Sato, Naoki Terada, Yukihiro Futagami, Masayuki Yokoyama, Yoshihito Fujimori, Keiya |
author_facet | Watanabe, Takafumi Soeda, Shu Nishiyama, Hiroshi Kiko, Yuichiroh Tokunaga, Hideki Shigeta, Shogo Yaegashi, Nobuo Yamada, Hidekazu Ohta, Tsuyoshi Nagase, Satoru Shoji, Tadahiro Kagabu, Masahiro Baba, Tsukasa Shimizu, Dai Sato, Naoki Terada, Yukihiro Futagami, Masayuki Yokoyama, Yoshihito Fujimori, Keiya |
author_sort | Watanabe, Takafumi |
collection | PubMed |
description | The aim of the present study was to evaluate the oncologic safety and reproductive outcome in patients with stage I epithelial ovarian cancer (EOC) treated with fertility-sparing surgery (FSS). Women aged ≤40 years with stage I EOC who had undergone FSS between 2000 and 2010 were retrospectively reviewed. Survival was examined using the Kaplan-Meier method and statistical significance was analyzed using the log-rank test. A total of 29 EOC patients (stage IA, n=14; stage IC1 n=6; stage IC3, n=9) from seven participating institutions belonging to the Tohoku Gynecologic Cancer Unit were enrolled. After a median follow-up duration of 60.6 months (range, 6–135 months), five patients (17.2%) experienced tumor recurrence. The respective five-year relapse-free survival (RFS) and overall survival (OS) rates were 90.9 and 100% for stage IA/IC1, and 43.8 and 87.5% for stage IC3. Significant differences in RFS were observed between stage IA/IC1 and IC3 patients (P=0.026). However, there was no significant difference in OS between patients with 1A/1C1 and those with 1C3 (P=0.712). After FSS, seven pregnancies occurred in five patients, which resulted in the birth of six healthy children. The results of the present study confirmed that FSS may be an acceptable treatment method for stage IA and IC1 EOC, exhibiting a favorable reproductive outcome. However, the safety of FSS for treating stage IC3 EOC is uncertain and warrants further investigation. |
format | Online Article Text |
id | pubmed-6904870 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | D.A. Spandidos |
record_format | MEDLINE/PubMed |
spelling | pubmed-69048702019-12-12 Clinical and reproductive outcomes of fertility-sparing surgery in stage I epithelial ovarian cancer Watanabe, Takafumi Soeda, Shu Nishiyama, Hiroshi Kiko, Yuichiroh Tokunaga, Hideki Shigeta, Shogo Yaegashi, Nobuo Yamada, Hidekazu Ohta, Tsuyoshi Nagase, Satoru Shoji, Tadahiro Kagabu, Masahiro Baba, Tsukasa Shimizu, Dai Sato, Naoki Terada, Yukihiro Futagami, Masayuki Yokoyama, Yoshihito Fujimori, Keiya Mol Clin Oncol Articles The aim of the present study was to evaluate the oncologic safety and reproductive outcome in patients with stage I epithelial ovarian cancer (EOC) treated with fertility-sparing surgery (FSS). Women aged ≤40 years with stage I EOC who had undergone FSS between 2000 and 2010 were retrospectively reviewed. Survival was examined using the Kaplan-Meier method and statistical significance was analyzed using the log-rank test. A total of 29 EOC patients (stage IA, n=14; stage IC1 n=6; stage IC3, n=9) from seven participating institutions belonging to the Tohoku Gynecologic Cancer Unit were enrolled. After a median follow-up duration of 60.6 months (range, 6–135 months), five patients (17.2%) experienced tumor recurrence. The respective five-year relapse-free survival (RFS) and overall survival (OS) rates were 90.9 and 100% for stage IA/IC1, and 43.8 and 87.5% for stage IC3. Significant differences in RFS were observed between stage IA/IC1 and IC3 patients (P=0.026). However, there was no significant difference in OS between patients with 1A/1C1 and those with 1C3 (P=0.712). After FSS, seven pregnancies occurred in five patients, which resulted in the birth of six healthy children. The results of the present study confirmed that FSS may be an acceptable treatment method for stage IA and IC1 EOC, exhibiting a favorable reproductive outcome. However, the safety of FSS for treating stage IC3 EOC is uncertain and warrants further investigation. D.A. Spandidos 2020-01 2019-11-22 /pmc/articles/PMC6904870/ /pubmed/31832189 http://dx.doi.org/10.3892/mco.2019.1954 Text en Copyright: © Watanabe et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
spellingShingle | Articles Watanabe, Takafumi Soeda, Shu Nishiyama, Hiroshi Kiko, Yuichiroh Tokunaga, Hideki Shigeta, Shogo Yaegashi, Nobuo Yamada, Hidekazu Ohta, Tsuyoshi Nagase, Satoru Shoji, Tadahiro Kagabu, Masahiro Baba, Tsukasa Shimizu, Dai Sato, Naoki Terada, Yukihiro Futagami, Masayuki Yokoyama, Yoshihito Fujimori, Keiya Clinical and reproductive outcomes of fertility-sparing surgery in stage I epithelial ovarian cancer |
title | Clinical and reproductive outcomes of fertility-sparing surgery in stage I epithelial ovarian cancer |
title_full | Clinical and reproductive outcomes of fertility-sparing surgery in stage I epithelial ovarian cancer |
title_fullStr | Clinical and reproductive outcomes of fertility-sparing surgery in stage I epithelial ovarian cancer |
title_full_unstemmed | Clinical and reproductive outcomes of fertility-sparing surgery in stage I epithelial ovarian cancer |
title_short | Clinical and reproductive outcomes of fertility-sparing surgery in stage I epithelial ovarian cancer |
title_sort | clinical and reproductive outcomes of fertility-sparing surgery in stage i epithelial ovarian cancer |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6904870/ https://www.ncbi.nlm.nih.gov/pubmed/31832189 http://dx.doi.org/10.3892/mco.2019.1954 |
work_keys_str_mv | AT watanabetakafumi clinicalandreproductiveoutcomesoffertilitysparingsurgeryinstageiepithelialovariancancer AT soedashu clinicalandreproductiveoutcomesoffertilitysparingsurgeryinstageiepithelialovariancancer AT nishiyamahiroshi clinicalandreproductiveoutcomesoffertilitysparingsurgeryinstageiepithelialovariancancer AT kikoyuichiroh clinicalandreproductiveoutcomesoffertilitysparingsurgeryinstageiepithelialovariancancer AT tokunagahideki clinicalandreproductiveoutcomesoffertilitysparingsurgeryinstageiepithelialovariancancer AT shigetashogo clinicalandreproductiveoutcomesoffertilitysparingsurgeryinstageiepithelialovariancancer AT yaegashinobuo clinicalandreproductiveoutcomesoffertilitysparingsurgeryinstageiepithelialovariancancer AT yamadahidekazu clinicalandreproductiveoutcomesoffertilitysparingsurgeryinstageiepithelialovariancancer AT ohtatsuyoshi clinicalandreproductiveoutcomesoffertilitysparingsurgeryinstageiepithelialovariancancer AT nagasesatoru clinicalandreproductiveoutcomesoffertilitysparingsurgeryinstageiepithelialovariancancer AT shojitadahiro clinicalandreproductiveoutcomesoffertilitysparingsurgeryinstageiepithelialovariancancer AT kagabumasahiro clinicalandreproductiveoutcomesoffertilitysparingsurgeryinstageiepithelialovariancancer AT babatsukasa clinicalandreproductiveoutcomesoffertilitysparingsurgeryinstageiepithelialovariancancer AT shimizudai clinicalandreproductiveoutcomesoffertilitysparingsurgeryinstageiepithelialovariancancer AT satonaoki clinicalandreproductiveoutcomesoffertilitysparingsurgeryinstageiepithelialovariancancer AT teradayukihiro clinicalandreproductiveoutcomesoffertilitysparingsurgeryinstageiepithelialovariancancer AT futagamimasayuki clinicalandreproductiveoutcomesoffertilitysparingsurgeryinstageiepithelialovariancancer AT yokoyamayoshihito clinicalandreproductiveoutcomesoffertilitysparingsurgeryinstageiepithelialovariancancer AT fujimorikeiya clinicalandreproductiveoutcomesoffertilitysparingsurgeryinstageiepithelialovariancancer |